TDP1 and cancer: Benzylidene derivatives of usnic acid, a discovered Tdp1 inhibitor, have shown to exhibit a half-maximal inhibitory constant (IC50) value of 100 μM against neoplastic cells and managed to reduce tumor sizes by 62–65% [14], confirming the cancer-impeding effects of Tdp inhibitors.